ArticleJournal of experimental & clinical cancer research : CR2015

Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.